ADC Biotech to build $11M bioconjugation facility in Wales

27th September 2017 Uncategorised 0

ADC Biotechnology, a Welsh company specializing in antibody-drug conjugate contract services, said it will invest $11 million to build a new facility in Deeside, North Wales.

More: ADC Biotech to build M bioconjugation facility in Wales
Source: fierce